CMS’s New AI-Powered Prior Authorization System: Will It Speed Up Approvals or Deny Seniors Critical Care? – Image for illustrative purposes only (Image credits: Unsplash)
The Centers for Medicare and Medicaid Services has started a limited pilot that uses artificial intelligence to review certain prior authorization requests. The goal is to shorten the time patients and providers spend waiting for decisions on procedures that often involve chronic pain or mobility issues. Early results remain mixed, with some reports of faster processing alongside concerns that delays could persist or even increase in specific cases.
Why the Agency Is Turning to Technology
Traditional prior authorization processes have long relied on paper forms, faxes, and manual reviews that stretch across days or weeks. CMS officials describe the current system as inefficient and prone to unnecessary administrative costs. The new approach combines digital submission tools with AI that flags potential issues for quicker human review by licensed clinicians. Agency leaders argue this combination can reduce waste while preserving clinical judgment on final approvals.
One stated aim is to replace outdated communication methods with standardized electronic systems. CMS Administrator Dr. Mehmet Oz has publicly called for an end to fax-based requests in favor of faster digital exchanges. Proposed rules would require responses to urgent requests within 24 hours and standard ones within 72 hours once the systems are fully adopted.
Scope of the Current Pilot Program
The WISeR model, which stands for Wasteful and Inappropriate Service Reduction, is running in six states: Texas, Ohio, Arizona, Oklahoma, New Jersey, and Washington. It focuses on a narrow set of services that officials have identified as higher risk for overuse or billing errors. These include epidural steroid injections, nerve stimulation implants, knee arthroscopy, and certain spinal procedures.
Many of these treatments are commonly requested by Medicare beneficiaries managing arthritis, back pain, or neurological conditions. The pilot does not apply to all Medicare services, and CMS has emphasized that AI serves only as a support tool. Licensed medical professionals retain responsibility for any denial decisions.
Key elements of the WISeR pilot
- States involved: Texas, Ohio, Arizona, Oklahoma, New Jersey, Washington
- Targeted services: epidural injections, nerve stimulators, knee arthroscopy, spinal treatments
- Final decisions: made by licensed clinicians, not AI alone
- Status: early implementation with ongoing monitoring
Questions About Delays and Oversight
Some providers and patient advocates report that wait times for certain approvals have lengthened since the pilot began. Senator Maria Cantwell of Washington has raised concerns that pain-management and spinal cases are taking two to four times longer in affected areas. Consumer groups worry that heavy reliance on algorithms could reduce meaningful human review and make it harder for patients to understand denial reasons.
Transparency remains a central issue. KFF has noted that automated tools may limit the depth of review when claims move through systems too quickly. Lawmakers have also pointed out that stronger guardrails proposed earlier for Medicare Advantage plans have not yet been finalized. These uncertainties leave open the possibility that the technology could either ease or complicate access depending on how oversight evolves.
Practical Steps for Beneficiaries
Patients facing a denial are encouraged to keep complete records of physician notes, test results, and prior communications. Requesting a peer-to-peer review or submitting additional documentation can sometimes resolve issues without a formal appeal. Healthcare experts stress that persistence and clear medical justification continue to be the most effective tools when navigating these processes.
Whether the pilot ultimately shortens waits or introduces new hurdles will depend on how CMS monitors outcomes and adjusts the system in the coming months. The agency continues to gather data from the six participating states before considering broader expansion.
